Posts Tagged ‘OHSU Knight Cancer Institute’

The V Foundation for Cancer Research has invited OHSU to submit applications for two of their research programs this cycle: The V Foundation Translational Myelodysplastic Syndromes Research Project Offers up to $400,000 over two years in support of a translational research project on Myelodysplastic Syndromes as it relates to people with or at risk for cancer. Deadlines Internal deadline: May 17, 2013 Letter of Intent: May 31, 2013 Full application (by invitation only): June 19, … Read More

The V Foundation for Cancer Research – Translational Awards provide up to $200,000 per year for three years to fund projects that intend to develop novel, translational approaches to the prevention, detection and treatment of human cancer. Collaboration of investigators from both the lab and clinic is required. Project teams must have a minimum of two scientists from the same facility and the team must possess basic and clinical research expertise. One application is permitted … Read More

The OHSU Knight Cancer Institute is now accepting applications for Pilot Project funding. The purpose of these $50,000 awards is to cultivate outstanding translational cancer research by assisting in the generation of preliminary data leading to peer-reviewed, national funding. This mechanism is intended to support clinical, basic, or population-based research that is cancer focused. Scientific excellence will be the key review element for all applications. Interdisciplinary research, in which investigators from disparate scientific areas collaborate to … Read More

The OHSU Center for Spatial Systems Biomedicine (OCSSB), a multidisciplinary center within the OHSU Knight Cancer Institute and School of Medicine, has been awarded $1 million by the W. M. Keck Foundation to support the world’s first microscope that integrates both light and electron microscope techniques. This state-of-the-art technology, being developed in collaboration with Hillsboro-based FEI, allows researchers to associate cell behavior to precise points in the cellular architecture. Researchers from around the globe, including OHSU, … Read More

OHSU researcher and Knight Cancer Institute Deputy Director Tomasz Beer, M.D., has been selected to participate in a prestigious, six-person Dream Team to fight advanced-stage prostate cancer. Funding for this collaborative initiative is provided by Stand Up to Cancer, the Prostate Cancer Foundation, and the American Association for Cancer Research. Dr. Beer will be working with researchers from four University of California campuses–San Francisco, Los Angeles, Santa Crus, and Davis–as well as the University of … Read More

If you’re a faculty member who is part of the Knight Cancer Institute or OHSU Heart Research Center, consider mentoring an undergraduate biology student through the Murdock Undergraduate Collaborative Research Program next summer. Mentors work with a Murdock Scholar for ten weeks during the summer on a project and continue to assist the scholar throughout the following year to prepare a final thesis and give a presentation at a special session of the Oregon Academy … Read More

The Knight Cancer Institute Seminar Series continues with a presentation on the “Characterization and Targeting of Leukemia Stem Cells” by Craig T. Jordan, PhD. Dr. Jordan is a Phillip and Marilyn Wehreim Professor of Medicine from the Division of Hematology/Oncology at the James P. Wilmot Cancer Center and Professor of Biomedical Genetics and the University of Rochester School of Medicine. The presentation will take place in the OHSU Hospital’s 8th floor conference room, 8B60, at 4 … Read More

OHSU’s Knight Cancer Institute has recruited Charles D. Blanke, M.D., chair-elect of SWOG, one of the largest National Cancer Institute-funded clinical trial networks. As leader of SWOG, Dr. Blanke will oversee $40 million in research funding annually. The Knight Cancer Institute is expected to benefit by receiving $20 to $25 million and increased access to SWOG clinical trials. Dr. Blanke’s recruitment supports the Knight Cancer Institute’s mission of being a leader in personalized cancer medicine. … Read More

Updated 6/7/12: The criteria for this funding opportunity have changed to include the acceptance of proposals for translational research projects. Therefore, we are extending the internal deadline to next Friday, June 15. ————————————————— OHSU has been invited by the V Foundation to apply for their V Scholar Program, an opportunity for young, talented cancer researchers to gain support in their development into successful, independent investigators. The two-year, $200,000 grant will provide funds directly to young scientists … Read More

The Macy Easom Cancer Research Foundation has partnered with world-class cancer and stem cell physician-scientists to bring together some of the best minds in the field in hopes of stimulating hepatoblastoma and other pediatric cancer research. OHSU is proud to host the Macy Easom Memorial Lectureship, which will be held in the OHSU Hospital’s eighth-floor auditorium on Tuesday, June 5th at 4 p.m. Dr. Stefano Cairo, Ph.D., a human geneticist at XenTech in Paris, France has … Read More